Overview
Employees
11-50
Total raised
$39M
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Mar 19, 2015 | Funding round | $18M |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 19, 2015 | A drug that could raise IQ? Balance Therapeutics raises $18M, conducting Down Syndrome trials | Close examination of the molecular basis of intellectual disability has been quite revealing: Looks like the learning and memory deficits in conditions ranging from Down Syndrome to Alzheimer’s might be caused by a similar mechanism in the ... |
| A drug that could raise IQ? Balance Therapeutics raises $18M, conducting Down Syndrome trials | Stanford spinout Balance Therapeutics just raised $18 million for its therapy that could raise the IQ of people with intellectual disability. It’s using a small molecule drug that has been around for decades – GABA-A antagonists – but ratio... | |
| Balance Therapeutics up to $21M in Series B for IQ-enhancing drug | Stanford spinout Balance Therapeutics just raised another $3 million from a single investor, according to a regulatory filing – bringing what appears to be a Series B round up to $21 million. The company is developing a drug that could, pot... |